We are live on ! Find out more
WIC

Willis Investment Counsel Portfolio holdings

AUM $2.1B
1-Year Est. Return 24.61%
This Fund
S&P 500
This Quarter Est. Return
-10.17%
1 Year Est. Return
+24.61%
3 Year Est. Return
+53.31%
5 Year Est. Return
+71.06%
10 Year Est. Return
+1,214.29%
AUM
$1.63B
AUM Growth
-$259M
Cap. Flow
-$56.3M
Cap. Flow %
-3.45%
Top 10 Hldgs %
26.61%
Holding
123
New
7
Increased
31
Reduced
70
Closed
8

Top Sells

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$16.5M
2
LLY icon
Eli Lilly
LLY
+$11.9M
3
GD icon
General Dynamics
GD
+$10.1M
4
LMT icon
Lockheed Martin
LMT
+$7.56M
5
KR icon
Kroger
KR
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 18.89%
2 Healthcare 14.58%
3 Financials 14.14%
4 Industrials 12.94%
5 Consumer Staples 12.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APA icon
76
APA Corp
APA
$13.2B
$5.33M 0.33%
152,838
+2,268
+2% +$96.4K
VLO icon
77
Valero Energy
VLO
$85.9B
$5.17M 0.32%
48,617
-37,883
-44% -$4.48M
HXL icon
78
Hexcel
HXL
$7.82B
$5.08M 0.31%
97,071
-611
-0.6% -$33.5K
VBR icon
79
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
$4.55M 0.28%
+30,405
New +$4.99M
ROST icon
80
Ross Stores
ROST
$81.9B
$4.42M 0.27%
62,949
+681
+1% +$60.6K
VB icon
81
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$3.94M 0.24%
+22,382
New +$4.32M
LLY icon
82
Eli Lilly
LLY
$1.06T
$3.31M 0.2%
10,216
-39,800
-80% -$11.9M
MEDP icon
83
Medpace
MEDP
$16.5B
$2.93M 0.18%
19,584
-37
-0.2% -$5.36K
NRC icon
84
NRC Health Common Stock
NRC
$450M
$2.62M 0.16%
68,396
+13,360
+24% +$483K
EVTC icon
85
Evertec
EVTC
$1.78B
$2.45M 0.15%
66,347
+25,787
+64% +$985K
NVDA icon
86
NVIDIA
NVDA
$5.42T
$2.41M 0.15%
+158,720
New +$3M
CSGS
87
DELISTED
CSG Systems International
CSGS
$2.29M 0.14%
38,317
+4,742
+14% +$287K
QLYS icon
88
Qualys
QLYS
$6.35B
$2.21M 0.14%
17,506
-318
-2% -$41.7K
GIL icon
89
Gildan
GIL
$10.6B
$2.13M 0.13%
+74,035
New +$2.37M
FIZZ icon
90
National Beverage
FIZZ
$3.01B
$1.84M 0.11%
37,682
-950
-2% -$44.3K
STRL icon
91
Sterling Infrastructure
STRL
$16.7B
$1.84M 0.11%
83,894
-1,475
-2% -$35.4K
DCI icon
92
Donaldson
DCI
$11.4B
$1.84M 0.11%
38,188
-505
-1% -$25.4K
FTDR icon
93
Frontdoor
FTDR
$6.26B
$1.58M 0.1%
65,570
+521
+0.8% +$14.1K
ATKR icon
94
Atkore
ATKR
$3.16B
$1.51M 0.09%
18,217
-414
-2% -$41.1K
META icon
95
Meta Platforms (Facebook)
META
$1.51T
$1.43M 0.09%
8,863
-266
-3% -$51.3K
FLR icon
96
Fluor
FLR
$7.96B
$1.41M 0.09%
58,035
-694
-1% -$18.6K
CDK
97
DELISTED
CDK Global, Inc.
CDK
$1M 0.06%
18,337
-1,390
-7% -$75.1K
OGN icon
98
Organon & Co
OGN
$3.57B
$826K 0.05%
24,465
+8,647
+55% +$303K
BLBD icon
99
Blue Bird Corp
BLBD
$2.18B
$693K 0.04%
75,201
-1,289
-2% -$18.1K
SEB icon
100
Seaboard Corp
SEB
$4.06B
$683K 0.04%
176
-128
-42% -$516K

Similar funds

Willis Investment Counsel's Q2 2022 Portfolio in Review

As of Q2 2022, Willis Investment Counsel held 123 positions worth $1.63B, down 14% from $1.89B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Willis Investment Counsel withdrew a net $56.3M in Q2 2022, closing 8 positions and reducing 70 holdings. Its most notable exit was Cerner Corp, an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Willis Investment Counsel opened a new position in Vanguard Morningstar Small-Cap Value ETF worth $4.55M.

  • Willis Investment Counsel's largest Q2 2022 buy was Vanguard Morningstar Small-Cap Value ETF: 30,405 shares worth $4.55M.
  • Willis Investment Counsel added most to Factset in Q2 2022, an estimated $7.24M increase.
  • Willis Investment Counsel's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $11.9M.
  • Willis Investment Counsel fully exited Cerner Corp in Q2 2022, selling an estimated $16.5M.
  • Willis Investment Counsel's ten largest holdings make up 27% of its $1.63B portfolio in Q2 2022.
  • Willis Investment Counsel opened 7 new positions and closed 8 in Q2 2022.
  • Willis Investment Counsel's portfolio value fell 14% quarter-over-quarter to $1.63B.

Based on Willis Investment Counsel's 13F filing for Q2 2022, filed 8 Aug 2022.